Table 3.

Correlation of Child-Pugh scores with the type of treatment at 4 and 12 weeks after treatment commencement

	All	Treatment		p valuea
		sorafenib	HAIC
Four weeks after treatment commenced
Evaluable	183	46	137
Maintained or improved	122 (66.7%)	23 (50.0%)	99 (72.3%)	0.006
Deteriorated	61 (33.3%)	23 (50.0%)	38 (27.7%)
Twelve weeks after treatment commenced
Evaluable	162	44	118
Maintained or improved	105 (64.8%)	21 (47.7%)	84 (71.2%)	0.005
Deteriorated	57 (35.2%)	23 (52.3%)	34 (28.8%)

HAIC, hepatic arterial infusion chemotherapy.

^aχ² test.